Micro
Emerging
Active
統合の課題がStrideの四半期業績に影響
New narrative with limited coverage — still forming.
スコア
0.2
勢い
▲ 0.0
記事
1
情報源
1
Sentiment Timeline
Event Timeline
仮説
Pending
期日: 2026年6月23日
LRN's operating margin will contract by 150-250 basis points in Q4 2024 compared to Q4 2023 specifically attributable to integration costs and operational redundancies
Pending
期日: 2026年7月23日
LRN stock price will underperform S&P 500 by 8-15% in the 60 days following Q4 earnings release due to integration-related margin compression concerns
Pending
期日: 2026年6月23日
Stride Health (LRN) Q4 2024 revenue will decline by 5-10% year-over-year due to integration disruptions, with recovery beginning in Q1 2025
タイムライン
初回検出3月 25, 2026
最終更新3月 25, 2026